Recruiting

Ultrasound & Imaging

Sponsor:

University of Kansas Medical Center

Code:

NCT04424472

Conditions

Renal Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ultrasonography

Study Details

Brief summary:

The aim of this study is to determine the utility of renal ultrasonography (US) in the detection of abdominal recurrences after definitive therapy for renal cell carcinoma (RCC) and compare the detection rate to that of cross-sectional imaging.

Conditions

Renal Cell Carcinoma

Study ID

NCT04424472

Start date

Jul 17, 2020

Status verified date

Aug, 2020

Completion date

Dec 1, 2022

Anticipated

Primary completion date

Jun 1, 2022

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients must be 18 year of age or older.
  • Patients having undergone radical or partial nephrectomy for the indication of renal cell carcinoma.
  • Most recent imaging study must have been either computed tomography (CT) or magnetic resonance imaging (MRI).

Exclusion Criteria:

  • Patients with pT4 disease (tumor invades beyond the Gerota fascia: including contiguous extension into the ipsilateral adrenal gland).
  • Patients with metastatic disease prior to time of surgery requiring systemic treatment.
  • Patients with another active cancer diagnosis requiring systemic treatment.
  • Patients with contrast allergies.
  • Patients with baseline chronic kidney disease (GFR < 45 ml/min/1.73 m2).

Study Design

Enrollment

50 participants

Anticipated

Intervention Model

Single group

Primary purpose

Diagnostic

Interventions and Outcome Measures

Arms

experimental: Ultrasonography

Patient will be scheduled to undergo an additional US by a blinded sonographer within 4 weeks of their most recent cross-sectional imaging that indicated a recurrence

Interventions

Ultrasonography

Abdominal Ultrasonography

Primary outcome measure

  • Utility of Renal Ultrasonography (US) in the detection of abdominal recurrences [ Time Frame: 4 weeks ]

Central Contacts and Locations

Central contacts

Katherine Glavin

913-588-8721kglavin@kumc.edu

Locations

University of Kansas Health System

Recruiting

Kansas City, Kansas, United States, 66160

More Information

Sponsor

University of Kansas Medical Center

Last update posted

Sep 1, 2020

Last verified

Aug, 2020

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Kansas Medical Center on 2020-09-01.